Search: CBD

Forbes Recognizes PharmCo Rx for its Expertise in CBD Products

MIAMI, Aug. 16, 2019 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Forbes in an article titled, It’s national CBD Day: Have You Tried These Products? by Jeanne Croteau. READ MORE: http://www.globenewswire.com/news-release/2019/08/16/1903066/0/en/Forbes-Recognizes-PharmCo-Rx-for-its-Expertise-in-CBD-Products.html

HempFusion, Inc., a Leading US hemp-based CBD Company, Closes US$36,000,000 Financing

DENVER, CO, Aug. 14, 2019 /PRNewswire/ – HempFusion, Inc. (“HempFusion” or the “Company”), a leading US hemp-based cannabidiol (“CBD“) Company with over 30 product SKU’s distributed to over 3,400 retailers, is pleased to announce the closing of brokered and non-brokered private placements of a total of 28,800,000 units of the Company (each, a “Unit“) at a price of US$1.25 per…

Why Banking and financing remain a serious struggle for CBD businesses

Hemp ranchers and organizations keep on experiencing issues financing their activities and verifying services from banks, even though the government officials’ calls the CBD growth as a legal and authentic business under the 2018 Farm Bill. Due to an absence of clear government banking guidelines and vulnerability from money related foundations, the businesses of CBD and hemp can blow away…

Harvest One Phase II Clinical Trials on Satipharm CBD GelPell Published in Peer-Reviewed Medical Journal

VANCOUVER, Aug. 13, 2019 /PRNewswire/ – Harvest One Inc. (“Harvest One” or the “Company”) (TSXV: HVT;OTCQX:HRVOF), through its wholly-owned subsidiary Satipharm Ltd. (“Satipharm”), today announced positive results of a Phase 2 clinical trial of its CBD GelPell® capsules in the management of Treatment Resistant Epilepsy (TRE) have been published in Epilepsy & Behaviour, a bimonthly peer-reviewed medical […] READ MORE: https://www.newcannabisventures.com/harvest-one-phase-ii-clinical-trials-on-satipharm-cbd-gelpell-published-in-peer-reviewed-medical-journal/

Can CBD Improve Your Sex Life?

No one ever complains about having great food, great friends, or great sex. Of those three, the last one may be the hardest for most people to find, and for those who have found it, there is always room for improvement. A lot goes into having a satisfying sex life, including open communication, physical compatibility, and emotional connection. There’s also…

Elixinol Global Transitions Leadership Ahead of Major CBD Growth

Exclusive Interview with Elixinol Global CEO Stratos Karousos and Chief Innovation Officer Paul Benhaim Since Paul Benhaim last spoke with New Cannabis Ventures in 2018, his company, Elixinol Global (ASX: EXL) (OTC: ELLXF), has continued to aggressively pursue international expansion through its three divisions. Benhaim, now Chief Innovation Officer of the company, and newly appointed CEO […] READ MORE: https://www.newcannabisventures.com/elixinol-global-transitions-leadership-ahead-of-major-cbd-growth/

Bhang Brings Hemp-derived CBD Product Portfolio to Spain, France, Italy, Belgium, Luxembourg & the U.K.

MIAMI, Aug. 06, 2019 (GLOBE NEWSWIRE) — Bhang Inc. (“Bhang” or the “Company”) (CSE: BHNG), a global cannabis house of brands with an extensive, award-winning portfolio of products, announced today that it has signed an agreement to import and distribute Bhang’s full suite of hemp-derived cannabidiol (CBD) products in key markets across Europe, with distribution into Spain, France, Italy, Belgium, Luxembourg…

CV Sciences Q2 CBD Revenue Grows 36% to $16.9 Million

CV Sciences, Inc. Reports Second Quarter 2019 Financial Results Record quarterly revenue Increased retail distribution by over 1,200 stores SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (“CV Sciences” or the “Company”) announced today its financial results for the quarter ended June 30, 2019. Second Quarter 2019 and Recent Financial and […] READ MORE: https://www.newcannabisventures.com/cv-sciences-q2-cbd-revenue-grows-36-to-16-9-million/

KushCo Holdings Launches New Division to Connect CBD Network to National Retail Chains

Expanding the platform by adding Retail Services division with experienced team will facilitate partnerships with large scale go-to-market operations focused on CBD mass distribution GARDEN GROVE, CA / ACCESSWIRE / August 6, 2019 / KushCo Holdings, Inc. (OTCQX:KSHB) (“KushCo” or the “Company”), announced the creation of their new Retail Services division. The new business unit will […] READ MORE: https://www.newcannabisventures.com/kushco-holdings-launches-new-division-to-connect-cbd-network-to-national-retail-chains/

Ignite UK confirms exclusive CBD partnership with WHSmith

VAUGHAN, ON, Aug. 6, 2019 /CNW/ – Ignite International Brands (U.K.), Ltd. (“Ignite”), a wholly owned subsidiary of Ignite International Brands, Ltd. (CSE:BILZ), today announced that WHSmith, a worldwide retail market leader, has submitted a purchase order and will begin to offer, under exclusive contract, Ignite’s leading CBD products at 276 retail travel stores in the United Kingdom starting August 2019.…